In vitro fungicidal activities of voriconazole, itraconazole, and amphotericin B against opportunistic moniliaceous and dematiaceous fungi

Journal of Clinical Microbiology

Volumn 39, Issue 3, 2001, Pages 954-958

  Espinel Ingroff, A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ITRACONAZOLE; VORICONAZOLE;

ARTICLE; ASPERGILLUS; CONCENTRATION RESPONSE; DILUTION; FUNGICIDAL ACTIVITY; FUSARIUM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OPPORTUNISTIC INFECTION; PAECILOMYCES LILACINUS; PRIORITY JOURNAL; RHIZOPUS; SCEDOSPORIUM; TRICHODERMA;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; FUNGI; HUMANS; ITRACONAZOLE; MICROBIAL SENSITIVITY TESTS; MYCOSES; OPPORTUNISTIC INFECTIONS; PYRIMIDINES; TRIAZOLES;

ASPERGILLUS; ASPERGILLUS SP.; ASPERGILLUS TERREUS; BIPOLARIS SPICIFERA; DACTYLARIA; FUNGI; FUSARIUM; FUSARIUM SP.; LONGIBRACHIATUM; PAECILOMYCES LILACINUS; PSEUDALLESCHERIA BOYDII; RHIZOPUS; RHIZOPUS ORYZAE; SCEDOSPORIUM; SCEDOSPORIUM PROLIFICANS; TRICHODERMA LONGIBRACHIATUM;

EID: 0035095296     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.3.954-958.2001     Document Type: Article

References (34)

1. Antifungal susceptibilities of Paecilomyces species
2. The emerging role of Fusarium infections in patients with cancer
3. Microdilution susceptibility testing of amphotericin B, itraconazole, and voriconazole against clinical isolates of Aspergillus and Fusarium species
4. Quality control limits for broth microdilution susceptibility tests of ten antifungal agents
5. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature
6. In vitro efficacy and fungicidal activity of voriconazole against Aspergillus and Fusarium species
7. Comparative in vitro activity of voriconazole (UK-109, 496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum
8. Itraconazole resistance in Aspergillus fumigatus
9. Spectrophotometric method of inoculum preparation for the in vitro susceptibility testing of filamentous fungi
10. Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi
11. Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi
12. In vitro activity of the new triazole voriconazole (UK-109, 496) against opportunistic filamentous and dimorphic fungi and common and emerging yeast pathogens
13. Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743, 872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts
14. In vitro activity of a new oral triazole, BMS-207147 (ER-30346)
15. Amphotericin B: 30 years of clinical use
16. Use of voriconazole in treatment of Scedosporium apiospermum infection: Case report
17. In vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi
18. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immius, and Histoplasma capsulatum
19. Comparative study of susceptibilities of germinated and ungerminated conidia of Aspergillus fumigatus to various antifungal agents
20. In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications
21. In vitro activity of voriconazole against selected fungi
22. Short communication: In vitro antifungal activity of six drugs against 13 clinical isolates of Ochroconis gallopava
23. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi
24. Reference method for broth dilution antifungal susceptibility testing of yeasts
25. In vitro activity of SCH-56592 and comparison with activities of amphotericin B and itraconazole against Aspergillus spp
26. Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models
27. In vitro studies of activity of voriconazole (UK-109, 496), a new triazole antifungal agent, against emerging and less common mold pathogens
28. Fatal disseminated Trichoderma longibrachiatum infection in an adult bone marrow transplant patient: Species identification and review of the literature
29. Infections due to dematiaceous fungi in organ transplant recipients: Case report and review
30. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole
31. Invasive aspergillosis caused by Aspergillus ustus: Case report and review
32. Disseminated trichosporonosis resistant to amphotericin B
33. Disseminated Aspergillus ustus infection following cardiac surgery
34. Lipid formulations of amphotericin B: Clinical efficacies and toxicities